Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 05, 2022

SELL
$48.37 - $66.5 $1,499 - $2,061
-31 Reduced 0.61%
5,057 $257,000
Q3 2021

Oct 12, 2021

BUY
$76.02 - $88.62 $10,490 - $12,229
138 Added 2.79%
5,088 $403,000
Q1 2020

Apr 21, 2020

BUY
$34.22 - $76.49 $33,501 - $74,883
979 Added 24.65%
4,950 $224,000
Q4 2019

Jan 13, 2020

BUY
$68.92 - $85.27 $273,681 - $338,607
3,971 New
3,971 $300,000
Q1 2019

Apr 02, 2019

SELL
$86.15 - $100.49 $32,047 - $37,382
-372 Closed
0 $0
Q4 2018

Jan 11, 2019

SELL
$84.14 - $125.42 $21,455 - $31,982
-255 Reduced 40.67%
372 $34,000
Q3 2018

Oct 16, 2018

BUY
$101.02 - $130.95 $63,339 - $82,105
627 New
627 $78,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.